Related Experiment Video

Updated: Jun 3, 2026

Spinal Cord Neurons Isolation and Culture from Neonatal Mice
07:49

Spinal Cord Neurons Isolation and Culture from Neonatal Mice

Published on: July 11, 2017

Ion channel blockers and spinal cord injury

Wang-Mi Liu1, Jia-Yan Wu, Fang-Cai Li

  • 1Department of Orthopedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Journal of Neuroscience Research
|March 12, 2011
PubMed

Insights

Secondary injury after spinal cord injury (SCI) involves ionic imbalance. Ion channel blockers show promise for SCI treatment by targeting these ionic disturbances, but further research is needed for clinical application.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Spinal cord injury (SCI) leads to progressive degeneration due to secondary cellular and molecular responses.
  • Disturbances in ionic homeostasis, particularly K(+), Na(+), and Ca(2+), are critical in early SCI pathology.
  • Previous research indicates ion channel blockers can impact chronic SCI.

Purpose of the Study:

  • To comprehensively review the effects of ion channel blockers on natural responses following SCI.
  • To explore combination therapy strategies based on ion homeostasis disruption in SCI.
  • To assess the therapeutic potential of ion channel blockers for SCI treatment.

Main Methods:

  • Literature review of studies on ion channel blockers and SCI.
  • Analysis of the role of ion homeostasis in SCI pathogenesis.
  • Evaluation of combination therapy approaches for SCI.

Main Results:

  • Ion channel blockers modulate the secondary injury cascade in SCI.
  • Dysregulation of K(+), Na(+), and Ca(2+) homeostasis is a key feature of SCI.
  • Evidence suggests ion channel blockers have potential therapeutic effects.

Conclusions:

  • Ion channel blockers represent a potential therapeutic avenue for SCI.
  • The complexity of ion channel interactions necessitates further investigation for clinical translation.
  • Targeting ionic disturbances offers a promising strategy for managing SCI progression.

More Related Videos

Accessing the Subdural Space of the Rodent Spinal Cord for Treatment Delivery07:54

Accessing the Subdural Space of the Rodent Spinal Cord for Treatment Delivery

Published on: August 8, 2025

A Contusive Model of Unilateral Cervical Spinal Cord Injury Using the Infinite Horizon Impactor07:28

A Contusive Model of Unilateral Cervical Spinal Cord Injury Using the Infinite Horizon Impactor

Published on: July 24, 2012

Related Concept Videos

Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Spinal Cord Injury ll: Pathophysiology01:14

Spinal Cord Injury ll: Pathophysiology

Spinal cord injury progresses through two interconnected phases: primary injury and secondary injury.Primary InjuryPrimary injury happens at the moment of trauma and involves immediate mechanical damage to the spinal cord.Compression happens when broken vertebrae, herniated discs, or accumulating blood (such as a hematoma) press directly against the spinal cord, distorting its normal shape and function. In cases of contusion, the cord is bruised by a blunt force (like penetrating injuries or...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
The Spinal Cord01:54

The Spinal Cord

The spinal cord is the body’s major nerve tract of the central nervous system, communicating afferent sensory information from the periphery to the brain and efferent motor information from the brain to the body. The human spinal cord extends from the hole at the base of the skull, or foramen magnum, to the level of the first or second lumbar vertebra.